Ionis Pharmaceuticals, Inc.
Compositions and methods for modulating TTR expression
Last updated:
Abstract:
Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.
Status:
Grant
Type:
Utility
Filling date:
25 Aug 2017
Issue date:
16 Jun 2020